The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance
M. Chen
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorZ-Q. Chen
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorP-G. Cui
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorX. Yao
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorY-M. Li
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorA-S. Li
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorJ-Q. Gong
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorY-H. Cao
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorM. Chen
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorZ-Q. Chen
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorP-G. Cui
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorX. Yao
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorY-M. Li
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorA-S. Li
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorJ-Q. Gong
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorY-H. Cao
Department of Clinical Dermatology and Immunology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
Search for more papers by this authorConflicts of interestNone declared.
Abstract
Summary Background Alteration of the p16INK4a gene by epigenetic changes has been described in some hyperproliferative skin diseases, but its importance in psoriasis has not yet been established.
Objectives To investigate the methylation status of the p16INK4a gene in psoriatic epidermis, its clinical significance and the possible epigenetic mechanisms of psoriasis.
Methods DNA and RNA specimens were obtained from the lesional epidermis of 56 patients with plaque psoriasis. Methylation-specific polymerase chain reaction (PCR) and DNA sequencing were used to detect the density and sites of methylation in the p16INK4a promoter region. The reverse transcription–PCR technique was applied to detect the mRNA expression of p16INK4a.
Results p16INK4a gene promoter methylation was shown in 17 of 56 (30%) patients with psoriasis. Psoriasis Area and Severity Index scores in patients showing methylation were higher than in those who did not (P < 0·05). The mRNA expression level of p16INK4a in the methylated group was significantly lower than in the unmethylated group (t = 2·515, P = 0·015). In the methylated group, about 50% of the CpG islands were methylated in the promoter region.
Conclusions Overall, methylation of the p16INK4a gene promoter is found in psoriatic epidermis, which is associated with the mRNA level of p16INK4a expression and activity of the disease. These data indicate that methylation of the p16INK4a promoter may play a potential role in the pathogenesis of psoriasis.
References
- 1 Linden KG, Weinstein GD. Psoriasis: current perspectives with an emphasis on treatment. Am J Med 1999; 107: 595–605.
- 2 Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 1995; 332: 581–8.
- 3 Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135: 1104–10.
- 4 Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701–5.
- 5 Uyemura K, Demer LL, Castle SC et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97: 2130–8.
- 6 Wrone-Smith T, Mitra RS, Thompson CB et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997; 151: 1321–9.
- 7 Elias AN, Barr RJ, Nanda VS. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene. Int J Dermatol 2004; 43: 889–92.
- 8 Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint. J Cutan Pathol 2001; 28: 57–64.
- 9 Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415–28.
- 10 Eden A, Gaudet F, Waghmare A et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455.
- 11 Gaudet F, Hodgson JG, Eden A et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300: 489–92.
- 12 Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–9.
- 13 Brown VL, Harwood CA, Crook T et al. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004; 122: 1284–92.
- 14 Herman JG, Graff JR, Myöhänen S et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–6.
- 15 Krueger GG, Duvic M. Epidemiology of psoriasis: clinical issues. J Invest Dermatol 1994; 102: S14–18.
- 16 Nickoloff BJ, Wrone-Smith T. Superantigens, autoantigens, and pathogenic T cells in psoriasis. J Invest Dermatol 1998; 110: 459–60.
- 17 Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98: 1878–87.
- 18 Hong K, Chu A, Ludviksson BR et al. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 1999; 162: 7480–91.
- 19 Nickoloff BJ, Schroder JM, Von Den Driesch P et al. Is psoriasis a T-cell disease? Exp Dermatol 2000; 9: 359–75.
- 20 Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–7.
- 21 Mark EB, Jonsson M, Asp J et al. Expression of genes involved in the regulation of p16 in psoriatic involved skin. Arch Dermatol Res 2006; 297: 459–67.
- 22 Nindl I, Meyer T, Schmook T et al. Human papillomavirus and overexpression of P16INK4a in non melanoma skin cancer. Dermatol Surg 2004; 30: 409–14.
- 23 Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 (Suppl.): 245–54.
- 24 Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3: 662–73.
- 25 Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6–21.
- 26 Peris K, Stanta G, Fargnoli MC et al. Reduced expression of CDKN2a/P16INK4a in mycosis fungoides. Arch Dermatol Res 1999; 291: 207–11.
- 27 Lodygin D, Yazdi AS, Sander CA et al. Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003; 22: 5519–24.
- 28 Van Doorn R, Gruis NA, Willemze R et al. Aberrant DNA methylation in cutaneous malignancies. Semin Oncol 2005; 32: 479–87.
- 29 Yildirim M, Inaloz HS, Baysal V et al. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 34–6.
- 30 Portugal M, Barak V, Ginsburg I et al. Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed Pharmacother 2007; 61: 412–22.
- 31 Govindarajan B, Klafter R, Miller MS et al. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med 2002; 8: 1–8.
- 32 Cerimele F, Battle T, Lynch R et al. Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr virus (EBV)-positive versus EBV-negative Burkitt’s lymphoma. Proc Natl Acad Sci USA 2005; 102: 175–9.
- 33 Hitchler MJ, Domann FE. An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 2007; 43: 1023–36.
